Institutions receiving federal funding will soon face mandatory oversight for all biohazards, including toxins and prions, regardless of whether genetic modification is involved. This sweeping proposal from the National Institutes of Health represents a fundamental shift in how biological research
While cloud-based applications remained secure, the compromise of on-premises systems halted the ability of a major manufacturer to fulfill essential medical hardware orders. This incident sent immediate shockwaves through the global healthcare sector, highlighting the precarious dependency on
Gland Pharma's Visakhapatnam Special Economic Zone Sterile Oncology Facility recently achieved a No Action Indicated status following a USFDA inspection with zero Form 483 observations. This significant regulatory outcome underscores the firm’s commitment to maintaining the highest quality
The proliferation of over one thousand high-containment laboratories in the United States since 9/11 has paradoxically increased the mathematical probability of a catastrophic accident. This startling statistic serves as the foundation for Annie Jacobsen’s investigation into the burgeoning threat
In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially
Strategic location within the Houston biotech hub provides Bristol Myers Squibb with access to a robust ecosystem of talent, infrastructure, and academic partnerships. This massive $2.3 billion investment represents a definitive shift toward securing the domestic supply chain and modernizing the
